What Zomiba is and what it is used for?
Zomiba contains the active substance bortezomib, also-called ‘proteasome inhibitor’. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, bortezomib can kill cancer cells.
Zomiba is used for the treatment of multiple myeloma (a cancer of the bone marrow) in patients older than 18 years:
Zomiba is used for the treatment of mantle cell lymphoma (a type of cancer affecting the lymph nodes) in patients 18 years or older in combination with the medicines rituximab, cyclophosphamide, doxorubicin and prednisone, for patients whose disease has not been previously treated and for whom blood stem cell transplantation is unsuitable.